The European Commission wants to make it easier for patients to access cheaper generic medicines, a draft EU document seen by Reuters shows, in a move that could cut the revenues of big pharmaceutical firms.
New Klick Health research published in Nature Digital Medicine says physicians could get a more comprehensive view of their patients’ health – and even help predict chronic disease early by assessing the interdependence of their health indicators and the body’s homeostasis system that controls them.
The COVID-19 pandemic sparked national concern about vulnerabilities in the drug supply chain. Many drugs procured in the United States are manufactured abroad. The pandemic disrupted the production of key pharmaceutical ingredients around the world, sparking fear about resulting shortages of key medicines. The system also struggled to keep pace with rising demand for drugs to treat patients with COVID-19. During this webinar, panelists will explore the impact of the pandemic on different facets of the drug supply chain and discuss policy options to strengthen the system.